Pancreatic cancer is notorious for being highly aggressive and difficult to treat. Survival rates for this disease have barely improved at all in the last four decades, with only five per cent of ...

Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, ...

Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This ...

From mapping the paths of cancer evolution, to the design and discovery of novel drugs - we are leading in innovative cancer informatics. Cancer is a complex, ever-changing set of diseases, and new ...

Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including ...

Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen ...

The ICR-CTSU is a CR-UK funded, internationally recognised methodologist led clinical trials unit, providing cancer-focussed clinical trial research expertise. We lead pioneering, efficient, ...

John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, and Honorary Consultant in Medical Oncology ...

Image: A cluster of breast cancer cells. Credit: Annie Cavanagh, Wellcome Images. A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer ...

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...